Orchard Therapeutics Q3 EPS $(0.29) Down From $(0.20) YoY

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.29) per share. This is a 45 percent decrease over losses of $(0.20) per share from the same period last year.

Orchard Therapeutics (NASDAQ:ORTX) reported quarterly losses of $(0.29) per share. This is a 45 percent decrease over losses of $(0.20) per share from the same period last year.

Total
0
Shares
Related Posts